» Articles » PMID: 24517962

Myogenic Tumors in Nevoid Basal Cell Carcinoma Syndrome

Overview
Specialty Pediatrics
Date 2014 Feb 13
PMID 24517962
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

In mice, activated Hedgehog (Hh) signaling induces tumors with myogenic differentiation. In humans, hyperactive Hh signaling due to germline PATCHED1 (PTCH1) mutations has been linked to nevoid basal cell carcinoma syndrome (NBCCS). We report an embryonal rhabdomyosarcoma in a 16-month-old girl with NBCCS and review the literature on myogenic neoplasms in NBCCS, including 8 fetal rhabdomyomas and 3 rhabdomyosarcomas. Of note, 3 population studies, including 255 individuals with NBCCS aged 4 months to 87 years, did not identify any myogenic tumors. Thus, myogenic tumors in NBCCS are rare and include both rhabdomyosarcomas and fetal rhabdomyomas.

Citing Articles

Myogenesis gone awry: the role of developmental pathways in rhabdomyosarcoma.

Gustafson A, Durbin A, Artinger K, Ford H Front Cell Dev Biol. 2025; 12:1521523.

PMID: 39902277 PMC: 11788348. DOI: 10.3389/fcell.2024.1521523.


Inhibition of primary cilia-hedgehog signaling axis triggers autophagic cell death and suppresses malignant progression of VHL wild-type ccRCC.

Tian S, Du S, Wang C, Zhang Y, Wang H, Fan Y Cell Death Dis. 2024; 15(10):739.

PMID: 39389955 PMC: 11466958. DOI: 10.1038/s41419-024-07085-8.


Context-dependent modulation of aggressiveness of pediatric tumors by individual oncogenic RAS isoforms.

Bauer J, Cuvelier N, Ragab N, Simon-Keller K, Nitzki F, Geyer N Oncogene. 2021; 40(31):4955-4966.

PMID: 34172934 PMC: 8342309. DOI: 10.1038/s41388-021-01904-4.


Genetic Predisposition to Solid Pediatric Cancers.

Capasso M, Montella A, Tirelli M, Maiorino T, Cantalupo S, Iolascon A Front Oncol. 2020; 10:590033.

PMID: 33194750 PMC: 7656777. DOI: 10.3389/fonc.2020.590033.


Molecular-Clinical Correlation in Pediatric Medulloblastoma: A Cohort Series Study of 52 Cases in Taiwan.

Wu K, Ho D, Jou S, Yu A, Tran H, Liang M Cancers (Basel). 2020; 12(3).

PMID: 32168907 PMC: 7139704. DOI: 10.3390/cancers12030653.


References
1.
Evans D, Ladusans E, Rimmer S, Burnell L, Thakker N, Farndon P . Complications of the naevoid basal cell carcinoma syndrome: results of a population based study. J Med Genet. 1993; 30(6):460-4. PMC: 1016416. DOI: 10.1136/jmg.30.6.460. View

2.
Yang S, Zhao C, Zhang Y, Liao S . Mediastinal fetal rhabdomyoma in nevoid basal cell carcinoma syndrome: a case report and review of the literature. Virchows Arch. 2011; 459(2):235-8. DOI: 10.1007/s00428-011-1108-8. View

3.
Hettmer S, Teot L, Van Hummelen P, Macconaill L, Bronson R, DallOsso C . Mutations in Hedgehog pathway genes in fetal rhabdomyomas. J Pathol. 2013; 231(1):44-52. PMC: 3875333. DOI: 10.1002/path.4229. View

4.
Lo Muzio L . Nevoid basal cell carcinoma syndrome (Gorlin syndrome). Orphanet J Rare Dis. 2008; 3:32. PMC: 2607262. DOI: 10.1186/1750-1172-3-32. View

5.
Hardisson D, Jimenez-Heffernan J, Nistal M, Picazo M, Tovar J, Contreras F . Neural variant of fetal rhabdomyoma and naevoid basal cell carcinoma syndrome. Histopathology. 1996; 29(3):247-52. DOI: 10.1111/j.1365-2559.1996.tb01398.x. View